2
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Conditions
Multiple Myeloma
2
Breast Neoplasms
2
Uterine Cervical Dysplasia
1
Sarcoma
1
Polycystic Ovary Syndrome
1
Peripheral Nervous System Diseases
1
Neuroblastoma
1
Neoplasms
1
Neoplasm Metastasis
1
Lymphoma
1
Leukemia
1
Insulin Resistance
1
Diabetes Mellitus
1
Central Nervous System Neoplasms
1
Cardiovascular Diseases
1
Cardiotoxicity
1
Burns
1
Interventions
Acupuncture Therapy
10
Exercise
7
Cryotherapy
6
Paclitaxel
5
Glutamine
5
Surveys and Questionnaires
3
Duloxetine Hydrochloride
3
Dexamethasone
3
Bortezomib
3
Acetylcysteine
3
pembrolizumab
2
enfortumab vedotin
2
Thioctic Acid
2
Tablets
2
Sodium Chloride
2
Saline Solution
2
Physical Therapy Modalities
2
Low-Level Light Therapy
2
Lenalidomide
2
Fish Oils
2
Fatty Acids, Omega-3
2
ziconotide
1
sagopilone
1
nicotinamide-beta-riboside
1
nabilone
1
glutamic acid diethyl ester
1
eribulin
1
allantoicase
1
Yoga
1
XELOX
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Peripheral Nervous System Diseases
×
Fenofibrate
×
Clear all
NCT07025005
2025-11-04
VRd MM Fibrate
Tanta University
Phase 4
Recruiting
44 enrolled